Publication | Closed Access

Msx2Gene Dosage Influences the Number of Proliferative Osteogenic Cells in Growth Centers of the Developing Murine Skull: A Possible Mechanism forMSX2-Mediated Craniosynostosis in Humans

SclerostinDevelopmental BiologyBone Morphogenic ProteinMsx2gene DosageMedicineCraniofacial DevelopmentCraniofacial GrowthCell BiologyDeveloping Murine SkullOsteocalcinStem CellsMandibular GrowthOsteoporosisBone MetabolismAnimal Craniofacial GrowthGrowth CentersHealth Sciences